A new report provides data from a prospective, single-center, Phase II trial of high-intensity focused ultrasound (HIFU) in prostate cancer hemiablation as a form of focal therapy. The study was carried out in Belgium. The new paper by van Velthoven et al. describes the outcomes of a cohort of 50 patients, all treated with prostate […]![]()
